Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Soochow UniversityActive in the last 2 years

Yuchen Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6123-3049; OpenAlex author ID A5101741650. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 3 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. Co-author DOI 10.1016/j.gendis.2025.101870↗
  2. Long Noncoding RNA LINC00578 Inhibits Ferroptosis in Pancreatic Cancer via Regulating SLC7A11 Ubiquitination. Co-author DOI 10.1155/2023/1744102↗
  3. RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression. Co-author DOI 10.1007/s13258-022-01217-0↗
  4. Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically resected pancreatic cancer patients. First author DOI 10.21037/gs-22-517↗
  5. Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. Co-author DOI 10.21037/jgo-21-303↗
  6. Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.682969↗
  7. Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis. First author DOI 10.7150/jca.48661↗
  8. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis. Co-author DOI 10.3892/ol.2018.8912↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Zhou · 7 shared papers, 2018–2026 · strength 1.09
  2. Haoran Li · 5 shared papers, 2021–2026 · strength 0.88
  3. Bin Yi · 5 shared papers, 2021–2026 · strength 0.83
  4. Yijun Wei · 3 shared papers, 2021–2026 · strength 0.55
  5. Zixiang Zhang · 4 shared papers, 2018–2022 · strength 0.52
  6. Jian Yang · 2 shared papers, 2022–2026 · strength 0.45
  7. Dongming Zhu · 2 shared papers, 2021–2023 · strength 0.31
  8. Jun Yao · 1 shared paper, 2026 · strength 0.29
  9. Ye Li · 2 shared papers, 2021–2022 · strength 0.28
  10. Dechun Li · 2 shared papers, 2021–2022 · strength 0.26
  11. Jun Yao · 2 shared papers, 2021–2022 · strength 0.26
  12. Jian Yang · 2 shared papers, 2021–2022 · strength 0.26
  13. Dongming Zhu · 2 shared papers, 2021–2022 · strength 0.26
  14. Yujie Huang · 2 shared papers, 2021–2022 · strength 0.26
  15. Jian Yang · 1 shared paper, 2023 · strength 0.18
  16. Jun Yao · 1 shared paper, 2023 · strength 0.18
  17. Jie Wang · 1 shared paper, 2022 · strength 0.16
  18. Qiuhua Liu · 1 shared paper, 2022 · strength 0.13
  19. Yi Zhang · 1 shared paper, 2022 · strength 0.13
  20. Chen Zhang · 1 shared paper, 2021 · strength 0.13
  21. Peng Du · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.